JAHA:台湾成人先天性心脏病2000-2014年期间流行病学趋势分析!

2018-02-08 xing.T MedSci原创

由此可见,该研究证实了ACHD患病率和医疗复杂性呈上升趋势。他们有发生快速心律失常的风险,较高的死亡率,意外死亡,这表明这些患者的医疗保健存在差距。

成人先天性心脏病(ACHD)人群将随着医学进展而有所增长,但具体数据不明确。近日,心血管疾病领域权威杂志JAHA上发表了一篇研究文章。研究人员旨在调查台湾人群中ACHD流行病学特征。

研究人员通过查找2000年-2014年的全台湾数据库找到1954年以后出生的ACHD患者。在2000年、2005年、2010年和2014年,在台湾18岁至59岁的人群中ACHD的患病率分别为140.53人、157.08人、182.45人和217.00人/10万人群(时间趋势增加,P<0.0001)。重度ACHD患者的百分比也随着时间的推移有所增加(P<0.0001),在2014年为11.70%。5种主要的ACHD诊断为室间隔缺损、继发孔房间隔缺损、动脉导管未闭、肺动脉瓣狭窄和法洛四联症。

严重和简单的ACHD患者50岁时无快速性心律失常的比例分别为0.574和0.710。绝大多数死亡病例死于心脏原因,其次是单纯ACHD患者发生恶性肿瘤以及严重ACHD患者外因/猝死/院外死亡。意外死亡比例为10%。与一般人群相比,标准化死亡率不仅在严重ACHD患者(3.164; 95%可信区间为2.664-3.664)较高,而且在单纯ACHD女性患者(1.704; 95%可信区间为1.499-1.909)也较高,死亡原因中心脏病、分娩和猝死比例较高。

由此可见,该研究证实了ACHD患病率和医疗复杂性呈上升趋势。他们有发生快速心律失常的风险,较高的死亡率,意外死亡,这表明这些患者的医疗保健存在差距。

原始出处:

Mei‐Hwan Wu,et al. Adult Congenital Heart Disease in a Nationwide Population 2000–2014: Epidemiological Trends, Arrhythmia, and Standardized Mortality Ratio.JAHA.2018. https://doi.org/10.1161/JAHA.117.007907

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1667564, encodeId=b907166e564ee, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Sat Jun 16 15:24:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287017, encodeId=7b1828e017ba, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Feb 11 08:25:35 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267719, encodeId=b873126e7194f, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369346, encodeId=30931369346af, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411294, encodeId=40d61411294c3, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449561, encodeId=7c61144956141, content=<a href='/topic/show?id=ea015383591' target=_blank style='color:#2F92EE;'>#成人先天性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53835, encryptionId=ea015383591, topicName=成人先天性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036b5479525, createdName=shizhenshan, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286296, encodeId=2d2928629612, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Feb 08 20:16:31 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1667564, encodeId=b907166e564ee, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Sat Jun 16 15:24:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287017, encodeId=7b1828e017ba, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Feb 11 08:25:35 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267719, encodeId=b873126e7194f, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369346, encodeId=30931369346af, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411294, encodeId=40d61411294c3, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449561, encodeId=7c61144956141, content=<a href='/topic/show?id=ea015383591' target=_blank style='color:#2F92EE;'>#成人先天性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53835, encryptionId=ea015383591, topicName=成人先天性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036b5479525, createdName=shizhenshan, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286296, encodeId=2d2928629612, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Feb 08 20:16:31 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
    2018-02-11 大爰

    学习了谢谢分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1667564, encodeId=b907166e564ee, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Sat Jun 16 15:24:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287017, encodeId=7b1828e017ba, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Feb 11 08:25:35 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267719, encodeId=b873126e7194f, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369346, encodeId=30931369346af, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411294, encodeId=40d61411294c3, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449561, encodeId=7c61144956141, content=<a href='/topic/show?id=ea015383591' target=_blank style='color:#2F92EE;'>#成人先天性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53835, encryptionId=ea015383591, topicName=成人先天性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036b5479525, createdName=shizhenshan, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286296, encodeId=2d2928629612, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Feb 08 20:16:31 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
    2018-02-10 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=1667564, encodeId=b907166e564ee, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Sat Jun 16 15:24:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287017, encodeId=7b1828e017ba, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Feb 11 08:25:35 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267719, encodeId=b873126e7194f, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369346, encodeId=30931369346af, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411294, encodeId=40d61411294c3, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449561, encodeId=7c61144956141, content=<a href='/topic/show?id=ea015383591' target=_blank style='color:#2F92EE;'>#成人先天性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53835, encryptionId=ea015383591, topicName=成人先天性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036b5479525, createdName=shizhenshan, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286296, encodeId=2d2928629612, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Feb 08 20:16:31 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
    2018-02-10 huirong
  5. [GetPortalCommentsPageByObjectIdResponse(id=1667564, encodeId=b907166e564ee, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Sat Jun 16 15:24:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287017, encodeId=7b1828e017ba, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Feb 11 08:25:35 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267719, encodeId=b873126e7194f, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369346, encodeId=30931369346af, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411294, encodeId=40d61411294c3, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449561, encodeId=7c61144956141, content=<a href='/topic/show?id=ea015383591' target=_blank style='color:#2F92EE;'>#成人先天性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53835, encryptionId=ea015383591, topicName=成人先天性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036b5479525, createdName=shizhenshan, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286296, encodeId=2d2928629612, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Feb 08 20:16:31 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
    2018-02-10 xugumin
  6. [GetPortalCommentsPageByObjectIdResponse(id=1667564, encodeId=b907166e564ee, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Sat Jun 16 15:24:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287017, encodeId=7b1828e017ba, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Feb 11 08:25:35 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267719, encodeId=b873126e7194f, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369346, encodeId=30931369346af, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411294, encodeId=40d61411294c3, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449561, encodeId=7c61144956141, content=<a href='/topic/show?id=ea015383591' target=_blank style='color:#2F92EE;'>#成人先天性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53835, encryptionId=ea015383591, topicName=成人先天性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036b5479525, createdName=shizhenshan, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286296, encodeId=2d2928629612, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Feb 08 20:16:31 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1667564, encodeId=b907166e564ee, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Sat Jun 16 15:24:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287017, encodeId=7b1828e017ba, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Feb 11 08:25:35 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267719, encodeId=b873126e7194f, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369346, encodeId=30931369346af, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411294, encodeId=40d61411294c3, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449561, encodeId=7c61144956141, content=<a href='/topic/show?id=ea015383591' target=_blank style='color:#2F92EE;'>#成人先天性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53835, encryptionId=ea015383591, topicName=成人先天性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=036b5479525, createdName=shizhenshan, createdTime=Sat Feb 10 10:24:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286296, encodeId=2d2928629612, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Feb 08 20:16:31 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
    2018-02-08 131****1460

    学习了受益匪浅

    0

相关资讯

Int J Cardiol:年龄和性别对先天性心脏病成人存活率和死亡原因的影响!

由此可见,女性CHD患者的死亡率比男性要高。随着年龄的增长,CV死亡有所降低,但CV死亡的原因发生了重大的暂时性变化。在40以上的患者中,心脏衰竭超过猝死是幸存者的主要死亡原因。

Circulation:成人先天性心脏病并非那么可怕

随着患者年龄增长,成人先天性心脏病(ACHD)发病率会持续升高,而长期生存率则会持续下降。最近,患者在三级ACHD中心随访的重要性被凸显出来。我们致力于在同一三级中心的大样本量患者中取样,评估患者预后和阐明死亡原因。

成人先天性心脏病治疗转诊特征

  美国学者的一项研究表明,美国大部分心脏儿科医生(PC)为心脏病 style=color:blue >成人先天性心脏病(ACHD)患者提供治疗;伴有成人共病为促成转诊的最常见原因。论文于2012年11月在线发表于《美国心脏病学会杂志》(J Am Coll Cardiol)。   相关临床指南推荐,中度/复杂性先天性心脏病成人患者的治疗应由ACHD受训医生指导